OCTOBER 9-11, 2024 ARLINGTON, VA

Menu

ABSTRACT SUBMISSION

You’re Invited

Present your research at the 2024 CBTN Summit poster session. For full submission guidelines, download here.

SUBMIT AN ABSTRACT

Poster session

The CBTN Summit Poster Session features an array of distinguished researchers, clinicians, and thought leaders from across the globe. Researchers have ample networking opportunities, skill-building workshops, and a showcase of cutting-edge research and technologies. Amazon Web Services provides a dynamic platform for our discussions and demonstrations.

From novice to expert

As part of our special focus on young investigators, we encourage submissions from trainees and faculty up to the Assistant Professor level. We will showcase your abstracts during our poster session event. Young investigator travel stipend sponsorships are being sought. More information about these stipends will be available in the coming weeks.

United Minds. Unlocking Cures.

Together, scientists share research discoveries using the latest multimodal and multi-omic data advancements to enhance pediatric brain tumor research.

Your Impact

Your contributions to the field are highly regarded, and your participation would be invaluable in driving innovative discussions.

Key Research Topics for the Poster session include Pediatric Brain Tumor

  • AI Methodologies
  • Assay Development
  • Atypical Teratoid Rhabdoid Tumor
  • Biological Correlates, Biomarkers
  • Blood Brain Barrier
  • Cancer Neuroscience
  • Craniopharyngioma
  • Clinical Outcomes
  • Data Science
  • Data Analytics
  • Diffuse Midline Glioma, Diffuse Intrinsic Pontine Glioma
  • Diversity, Equity, and Inclusion
  • Developmental Therapeutics
  • Drug/CRISPR Screen
  • Embryonal Tumor with Multilayered Rosettes (ETMR), Other Embryonal Tumors, Rare tumors
  • Ependymoma
  • Epidemiology
  • Genomics, Epigenomics, Metabolomics
  • Germ Cell Tumors
  • High Grade Glioma
  • Imaging
  • Immune-, Cell-, Gene-, and Viral-Based Therapies
  • Low Grade Glioma
  • Medulloblastoma
  • Molecular Characterization
  • Multimodal (more than 1 data type)
  • EHR
  • Multi-omic
  • Predisposition Syndromes
  • Neurosurgery, Drug Delivery
  • Others (not fitting any other category)
  • Preclinical Models, Drug Discovery
  • Radiation Oncology
  • Research Platforms
  • Target Identification
  • Technology
  • Tumor Biology, Stem Cells, Models
  • Tumor Evolution
  • Tumor Microenvironment
  • Tumor Subtyping

Submissions are accepted until August 30, 2024. Submit an abstract here.